Top Pharmaceuticals stocks in Australia
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
CSLCSL | AU$134.12bn | 34.96 | 1.38% |
NEUNeuren Pharmaceuticals | AU$2.64bn | 16.77 | n/a |
SIGSigma Healthcare | AU$1.96bn | 293.63 | 0.79% |
CUVClinuvel Pharmaceuticals | AU$774.47m | 25.63 | 0.32% |
MYXMayne Pharma | AU$442.79m | n/a | n/a |
BOTBotanix Pharmaceuticals | AU$433.20m | n/a | n/a |
PBPProbiotec | AU$234.21m | 25.76 | 2.43% |
RCERecce Pharmaceuticals | AU$122.22m | n/a | n/a |
VLSVita Life Sciences | AU$120.70m | 12.9 | 4.21% |
NXSNext Science | AU$84.59m | n/a | n/a |
BIOBiome Australia | AU$65.72m | n/a | n/a |
PAAPharmaust | AU$65.46m | n/a | n/a |
IHLIncannex Healthcare | AU$65.07m | n/a | n/a |
VITVitura Health | AU$51.83m | 5.46 | 11.11% |
SPLStarpharma Holdings | AU$45.30m | n/a | n/a |
LGPLittle Green Pharma | AU$37.51m | n/a | n/a |
MVPMedical Developments International | AU$33.66m | n/a | n/a |
IMCImmuron | AU$20.50m | n/a | n/a |
ACRAcrux | AU$19.41m | n/a | n/a |
SNTSyntara | AU$15.79m | n/a | n/a |